Pediatric Anti Hypertensive Drugs: Advances in Treatment for Younger Patients by 2026
Childhood Hypertension: A Growing Concern Needing Tailored Solutions
Hypertension, once rare in children, now affects 3-5% of pediatric populations due to rising obesity and sedentary lifestyles. Traditional anti hypertensive drugs are often formulated for adults, posing risks of dosing errors or inadequate efficacy. By 2026, pediatric-specific drug development is accelerating, with...
0 Commentarios
0 Acciones
107 Views